Cargando…
Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
BACKGROUND: In order to utilize polygenic risk scores (PRSs) for Alzheimer’s disease (AD) in a meaningful way, influential factors (i.e. training set) and prediction across groups such as APOE e4 (APOE4) genotype as well as associations to dementia-related biomarkers should be explored. Therefore, w...
Autores principales: | Stocker, Hannah, Trares, Kira, Beyer, Léon, Perna, Laura, Rujescu, Dan, Holleczek, Bernd, Beyreuther, Konrad, Gerwert, Klaus, Schöttker, Ben, Brenner, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386275/ https://www.ncbi.nlm.nih.gov/pubmed/37516890 http://dx.doi.org/10.1186/s13195-023-01277-8 |
Ejemplares similares
-
Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers
por: Stocker, Hannah, et al.
Publicado: (2023) -
Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
por: Stocker, H., et al.
Publicado: (2020) -
Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies
por: Nguyen, Thi Ngoc Mai, et al.
Publicado: (2022) -
Correction: Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
por: Stocker, H., et al.
Publicado: (2021) -
Aβ misfolding in blood plasma measured by immuno‐infrared‐sensor as an age‐independent risk marker of Alzheimer's disease
por: Möllers, Tobias, et al.
Publicado: (2021)